Program Indication Early Pre-Clinical Late Pre-Clinical Phase 1 Phase 2
ML-004 ASD
Alzheimer’s Agitation
ML-007 Dyskinesias
ML-007 Schizophrenia
ML-009 Dyskinesias
ML-016 Anhedonia

Clinical Programs

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is characterized by impaired sociability and communication along with restricted, repetitive patterns of behavior. Studies show that in the US, 800k-1.35m children under 18 years of age have ASD.


Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive, irreversible neurodegenerative disorder that slowly erodes memory and cognitive skills. Initially, a person with AD may suffer memory lapses, such as forgetting familiar words or the location of everyday objects.



Dyskinesias are uncontrolled, involuntary movements of the body. They are often associated with a dopamine replacement medication, such as levodopa, that is used in the treatment of Parkinson’s disease, schizophrenia, and Huntington’s disease.



Schizophrenia is a serious mental disorder that causes a range of symptoms associated with thinking (cognition), behavior, and emotions. People with schizophrenia interpret reality in a way that is often disabling.